Envista Holdings (NVST) Asset Writedowns and Impairment (2019 - 2026)
Envista Holdings' (NVST) quarterly Asset Writedowns and Impairment came in at $4.4 million in Q2 2026, up 238.46% year-on-year from $1.3 million in Q2 2025, and down 39.73% quarter-over-quarter from $7.3 million in Q4 2025.
Envista Holdings (NVST) Asset Writedowns and Impairment (2019 - 2026) Analysis & Trends
Envista Holdings' Asset Writedowns and Impairment history runs 8 years deep, the most recent figure standing at $4.4 million for Q2 2026.
- On a quarterly basis, Asset Writedowns and Impairment rose 238.46% year-over-year to $4.4 million in Q2 2026; TTM through Apr 2026 was $11.7 million, a 98.99% decrease from a year earlier, with the FY2025 full-year figure at $9.5 million, down 46.93% from the prior year.
- Asset Writedowns and Impairment retreated to $4.4 million in Q2 2026 per NVST's latest filing, from $7.3 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.2 billion in Q2 2024 and bottomed at -$3.3 million in Q4 2023.
- The 5-year median for Asset Writedowns and Impairment is $2.0 million (2023), against an average of $98.2 million.
- Across the five-year window, Asset Writedowns and Impairment tumbled 466.67% in 2023 and jumped 284.21% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $900000.0 in 2022, then tumbled by 466.67% to -$3.3 million in 2023, then surged by 157.58% to $1.9 million in 2024, then soared by 284.21% to $7.3 million in 2025, then sank by 39.73% to $4.4 million in 2026.
- Per Business Quant, the three latest NVST Asset Writedowns and Impairment figures stand at $4.4 million (Q2 2026), $7.3 million (Q4 2025), and $1.3 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 4.40 Mn |
| Apr 3, 2026 | 4.40 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Mar 28, 2025 | 1.30 Mn |
| Mar 28, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Jun 28, 2024 | 1.15 Bn |
| Jun 28, 2024 | 1.15 Bn |
| Mar 29, 2024 | 4.50 Mn |
| Mar 29, 2024 | 4.50 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 900,000.00 |
| Dec 31, 2022 | 900,000.00 |
| Sep 30, 2022 | 600,000.00 |
| Sep 30, 2022 | 600,000.00 |